Kidney biomarkers: clinical aspects and laboratory determination
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Amsterdam
Academic Press
2020
|
| Schlagworte: | |
| Online-Zugang: | TUM01 |
| Beschreibung: | Includes index Further reading -- Chapter 2: Utility of the ''omics ́́in kidney disease: Methods of analysis, sampling considerations, and technical approa ... -- Introduction -- Statistical methods in analysis and interpretation of biomarkers in kidney disease -- Metrics for prediction performance (diagnostic potential) -- Quantification of prediction performance -- True positive rate and false positive rate -- Receiver-operating characteristic curve -- Summary indices -- Area under the ROC curve (AUC) -- Optimal prediction threshold -- Partial area under the curve Limitations of statistical metrics used for prediction performance -- Metrics to evaluating incremental diagnostic value -- Incremental value: How to evaluate? -- Improvement in discrimination -- Improvement in reclassification -- Net reclassification improvement -- Categorical net reclassification improvement -- Weighted net reclassification improvement -- Category-free net reclassification improvement -- Integrated discrimination improvement -- Decision and clinical use of analytic measures -- Recommendations for sample collection, storage, and preparation -- Tissue samples -- Biofluids Nontargeted versus targeted analysis -- Proteomics and metabolomics in nephrology -- Potential impact of proteomics and metabolomics in renal diseases -- Proteomics and the kidney -- The proteomics sample -- Urine -- Kidney tissue and cell culture -- Techniques used in proteome analysis -- Proteomics methods based on mass spectrometry -- First step: Protein separation -- Gel-based proteome analysis -- Gel-free proteome analysis -- Liquid chromatography (LC) -- Capillary electrophoresis -- Second step: Protein identification Two-dimensional gel electrophoresis coupled with mass spectrometry (2DE-MS) -- Liquid chromatography coupled to mass spectrometry (LC-MS/MS) -- Capillary electrophoresis coupled with mass spectrometry (CE-MS) -- Matrix-assisted laser desorption/ionization-time of flight coupled with mass spectrometry (MALDI-TOF/MS) -- Solid-phase chromatography coupled with mass spectrometry (SELDI-MS) -- Differential protein profiling -- Mass spectrometry -- (a) Peptide mass fingerprinting -- (b) Electrospray ionization -- (c) Peptide sequencing using tandem mass spectrometers |
| Beschreibung: | 1 Online-Ressource |
| ISBN: | 9780128163740 0128163747 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV047050067 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 201207s2020 |||| o||u| ||||||eng d | ||
| 020 | |a 9780128163740 |9 978-0-12-816374-0 | ||
| 020 | |a 0128163747 |9 0-12-816374-7 | ||
| 035 | |a (ZDB-4-NLEBK)2348381 | ||
| 035 | |a (OCoLC)1226706746 | ||
| 035 | |a (DE-599)BVBBV047050067 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-91 | ||
| 082 | 0 | |a 616.61075 | |
| 245 | 1 | 0 | |a Kidney biomarkers |b clinical aspects and laboratory determination |c edited by Seema S. Ahuja, Brian Castillo |
| 264 | 1 | |a Amsterdam |b Academic Press |c 2020 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes index | ||
| 500 | |a Further reading -- Chapter 2: Utility of the ''omics ́́in kidney disease: Methods of analysis, sampling considerations, and technical approa ... -- Introduction -- Statistical methods in analysis and interpretation of biomarkers in kidney disease -- Metrics for prediction performance (diagnostic potential) -- Quantification of prediction performance -- True positive rate and false positive rate -- Receiver-operating characteristic curve -- Summary indices -- Area under the ROC curve (AUC) -- Optimal prediction threshold -- Partial area under the curve | ||
| 500 | |a Limitations of statistical metrics used for prediction performance -- Metrics to evaluating incremental diagnostic value -- Incremental value: How to evaluate? -- Improvement in discrimination -- Improvement in reclassification -- Net reclassification improvement -- Categorical net reclassification improvement -- Weighted net reclassification improvement -- Category-free net reclassification improvement -- Integrated discrimination improvement -- Decision and clinical use of analytic measures -- Recommendations for sample collection, storage, and preparation -- Tissue samples -- Biofluids | ||
| 500 | |a Nontargeted versus targeted analysis -- Proteomics and metabolomics in nephrology -- Potential impact of proteomics and metabolomics in renal diseases -- Proteomics and the kidney -- The proteomics sample -- Urine -- Kidney tissue and cell culture -- Techniques used in proteome analysis -- Proteomics methods based on mass spectrometry -- First step: Protein separation -- Gel-based proteome analysis -- Gel-free proteome analysis -- Liquid chromatography (LC) -- Capillary electrophoresis -- Second step: Protein identification | ||
| 500 | |a Two-dimensional gel electrophoresis coupled with mass spectrometry (2DE-MS) -- Liquid chromatography coupled to mass spectrometry (LC-MS/MS) -- Capillary electrophoresis coupled with mass spectrometry (CE-MS) -- Matrix-assisted laser desorption/ionization-time of flight coupled with mass spectrometry (MALDI-TOF/MS) -- Solid-phase chromatography coupled with mass spectrometry (SELDI-MS) -- Differential protein profiling -- Mass spectrometry -- (a) Peptide mass fingerprinting -- (b) Electrospray ionization -- (c) Peptide sequencing using tandem mass spectrometers | ||
| 650 | 4 | |a Kidneys |x Diseases |x Molecular diagnosis | |
| 650 | 4 | |a Biochemical markers | |
| 700 | 1 | |a Ahuja, Seema S. |e Sonstige |4 oth | |
| 700 | 1 | |a Castillo, Brian |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780128159231 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 0128159235 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 0128159235 |
| 912 | |a ZDB-4-NLEBK | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032457455 | ||
| 966 | e | |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2348381 |l TUM01 |p ZDB-4-NLEBK |q TUM_PDA_EBSCOMED |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804182037270102016 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| building | Verbundindex |
| bvnumber | BV047050067 |
| collection | ZDB-4-NLEBK |
| ctrlnum | (ZDB-4-NLEBK)2348381 (OCoLC)1226706746 (DE-599)BVBBV047050067 |
| dewey-full | 616.61075 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.61075 |
| dewey-search | 616.61075 |
| dewey-sort | 3616.61075 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03749nmm a2200445zc 4500</leader><controlfield tag="001">BV047050067</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">201207s2020 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128163740</subfield><subfield code="9">978-0-12-816374-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0128163747</subfield><subfield code="9">0-12-816374-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-NLEBK)2348381</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1226706746</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047050067</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.61075</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Kidney biomarkers</subfield><subfield code="b">clinical aspects and laboratory determination</subfield><subfield code="c">edited by Seema S. Ahuja, Brian Castillo</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam</subfield><subfield code="b">Academic Press</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Further reading -- Chapter 2: Utility of the ''omics ́́in kidney disease: Methods of analysis, sampling considerations, and technical approa ... -- Introduction -- Statistical methods in analysis and interpretation of biomarkers in kidney disease -- Metrics for prediction performance (diagnostic potential) -- Quantification of prediction performance -- True positive rate and false positive rate -- Receiver-operating characteristic curve -- Summary indices -- Area under the ROC curve (AUC) -- Optimal prediction threshold -- Partial area under the curve</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Limitations of statistical metrics used for prediction performance -- Metrics to evaluating incremental diagnostic value -- Incremental value: How to evaluate? -- Improvement in discrimination -- Improvement in reclassification -- Net reclassification improvement -- Categorical net reclassification improvement -- Weighted net reclassification improvement -- Category-free net reclassification improvement -- Integrated discrimination improvement -- Decision and clinical use of analytic measures -- Recommendations for sample collection, storage, and preparation -- Tissue samples -- Biofluids</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Nontargeted versus targeted analysis -- Proteomics and metabolomics in nephrology -- Potential impact of proteomics and metabolomics in renal diseases -- Proteomics and the kidney -- The proteomics sample -- Urine -- Kidney tissue and cell culture -- Techniques used in proteome analysis -- Proteomics methods based on mass spectrometry -- First step: Protein separation -- Gel-based proteome analysis -- Gel-free proteome analysis -- Liquid chromatography (LC) -- Capillary electrophoresis -- Second step: Protein identification</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Two-dimensional gel electrophoresis coupled with mass spectrometry (2DE-MS) -- Liquid chromatography coupled to mass spectrometry (LC-MS/MS) -- Capillary electrophoresis coupled with mass spectrometry (CE-MS) -- Matrix-assisted laser desorption/ionization-time of flight coupled with mass spectrometry (MALDI-TOF/MS) -- Solid-phase chromatography coupled with mass spectrometry (SELDI-MS) -- Differential protein profiling -- Mass spectrometry -- (a) Peptide mass fingerprinting -- (b) Electrospray ionization -- (c) Peptide sequencing using tandem mass spectrometers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Kidneys</subfield><subfield code="x">Diseases</subfield><subfield code="x">Molecular diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemical markers</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ahuja, Seema S.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Castillo, Brian</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780128159231</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">0128159235</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">0128159235</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032457455</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2348381</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCOMED</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV047050067 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T16:07:39Z |
| indexdate | 2024-07-10T09:01:11Z |
| institution | BVB |
| isbn | 9780128163740 0128163747 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032457455 |
| oclc_num | 1226706746 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource |
| psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCOMED |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | Academic Press |
| record_format | marc |
| spelling | Kidney biomarkers clinical aspects and laboratory determination edited by Seema S. Ahuja, Brian Castillo Amsterdam Academic Press 2020 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Includes index Further reading -- Chapter 2: Utility of the ''omics ́́in kidney disease: Methods of analysis, sampling considerations, and technical approa ... -- Introduction -- Statistical methods in analysis and interpretation of biomarkers in kidney disease -- Metrics for prediction performance (diagnostic potential) -- Quantification of prediction performance -- True positive rate and false positive rate -- Receiver-operating characteristic curve -- Summary indices -- Area under the ROC curve (AUC) -- Optimal prediction threshold -- Partial area under the curve Limitations of statistical metrics used for prediction performance -- Metrics to evaluating incremental diagnostic value -- Incremental value: How to evaluate? -- Improvement in discrimination -- Improvement in reclassification -- Net reclassification improvement -- Categorical net reclassification improvement -- Weighted net reclassification improvement -- Category-free net reclassification improvement -- Integrated discrimination improvement -- Decision and clinical use of analytic measures -- Recommendations for sample collection, storage, and preparation -- Tissue samples -- Biofluids Nontargeted versus targeted analysis -- Proteomics and metabolomics in nephrology -- Potential impact of proteomics and metabolomics in renal diseases -- Proteomics and the kidney -- The proteomics sample -- Urine -- Kidney tissue and cell culture -- Techniques used in proteome analysis -- Proteomics methods based on mass spectrometry -- First step: Protein separation -- Gel-based proteome analysis -- Gel-free proteome analysis -- Liquid chromatography (LC) -- Capillary electrophoresis -- Second step: Protein identification Two-dimensional gel electrophoresis coupled with mass spectrometry (2DE-MS) -- Liquid chromatography coupled to mass spectrometry (LC-MS/MS) -- Capillary electrophoresis coupled with mass spectrometry (CE-MS) -- Matrix-assisted laser desorption/ionization-time of flight coupled with mass spectrometry (MALDI-TOF/MS) -- Solid-phase chromatography coupled with mass spectrometry (SELDI-MS) -- Differential protein profiling -- Mass spectrometry -- (a) Peptide mass fingerprinting -- (b) Electrospray ionization -- (c) Peptide sequencing using tandem mass spectrometers Kidneys Diseases Molecular diagnosis Biochemical markers Ahuja, Seema S. Sonstige oth Castillo, Brian Sonstige oth Erscheint auch als Druck-Ausgabe 9780128159231 Erscheint auch als Druck-Ausgabe 0128159235 |
| spellingShingle | Kidney biomarkers clinical aspects and laboratory determination Kidneys Diseases Molecular diagnosis Biochemical markers |
| title | Kidney biomarkers clinical aspects and laboratory determination |
| title_auth | Kidney biomarkers clinical aspects and laboratory determination |
| title_exact_search | Kidney biomarkers clinical aspects and laboratory determination |
| title_exact_search_txtP | Kidney biomarkers clinical aspects and laboratory determination |
| title_full | Kidney biomarkers clinical aspects and laboratory determination edited by Seema S. Ahuja, Brian Castillo |
| title_fullStr | Kidney biomarkers clinical aspects and laboratory determination edited by Seema S. Ahuja, Brian Castillo |
| title_full_unstemmed | Kidney biomarkers clinical aspects and laboratory determination edited by Seema S. Ahuja, Brian Castillo |
| title_short | Kidney biomarkers |
| title_sort | kidney biomarkers clinical aspects and laboratory determination |
| title_sub | clinical aspects and laboratory determination |
| topic | Kidneys Diseases Molecular diagnosis Biochemical markers |
| topic_facet | Kidneys Diseases Molecular diagnosis Biochemical markers |
| work_keys_str_mv | AT ahujaseemas kidneybiomarkersclinicalaspectsandlaboratorydetermination AT castillobrian kidneybiomarkersclinicalaspectsandlaboratorydetermination |